Literature DB >> 11577137

Time resolved fluorometric immunoassay, using europium labelled antihuman IgG, for the detection of human tetanus antitoxin in serum.

P A Maple1, C S Jones, N J Andrews.   

Abstract

A time resolved fluorometric immunoassay (TRFIA) has been developed and compared with an in house enzyme linked immunosorbent assay (ELISA) and commercial ELISA (Bindazyme) for the detection of tetanus antitoxin in human sera. A panel of 132 sera submitted for routine testing was used. Scatterplots showed a high degree of correlation between all three assays, although some divergence of results was apparent for low titre sera when comparing in house ELISA results with Bindazyme ELISA and TRFIA results. The TRFIA appeared to be more sensitive than the in house ELISA, and the Bindazyme assay compared well with the TRFIA. The intra-assay precision of all three assays, in terms of percentage coefficient of variation (%CV), was between 2.0% and 4.0%. The interassay precision ranged from 5% to 8% for the in house ELISA, 13% to 19% for the Bindazyme assay, and 11% to 13% for TRFIA. Both Bindazyme and TRFIA assays were simple to perform, accurate, reproducible, and amenable to automation. A particular benefit of the TRFIA was its large dynamic range, enabling tetanus antitoxin values of 0.01 IU/ml to 50 IU/ml to be measured with just one dilution of serum. TRFIA appears to be a useful serological technique worthy of further development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11577137      PMCID: PMC1731303          DOI: 10.1136/jcp.54.10.812

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Testing for neutralising potential of serum antibodies to tetanus and diphtheria toxin.

Authors:  D Sesardic; M J Corbel
Journal:  Lancet       Date:  1992-09-19       Impact factor: 79.321

2.  Tetanus associated with body piercing.

Authors:  C D O'Malley; N Smith; R Braun; D R Prevots
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

3.  ELISA for the routine determination of antitoxic immunity to tetanus.

Authors:  O Simonsen; M W Bentzon; I Heron
Journal:  J Biol Stand       Date:  1986-07

Review 4.  Diphtheria and tetanus toxoids.

Authors:  J W Smith
Journal:  Br Med Bull       Date:  1969-05       Impact factor: 4.291

5.  A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera.

Authors:  M E Melville-Smith; V A Seagroatt; J T Watkins
Journal:  J Biol Stand       Date:  1983-04

6.  Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay.

Authors:  H Aggerbeck; B Nørgaard-Pedersen; I Heron
Journal:  J Immunol Methods       Date:  1996-04-19       Impact factor: 2.303

7.  Detection of tetanus antitoxin using Eu(3+)-labeled anti-human immunoglobulin G monoclonal antibodies in a time-resolved fluorescence immunoassay.

Authors:  J P Schröder; W D Kuhlmann
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

  7 in total
  3 in total

1.  Comparison of five commercial anti-tetanus toxoid immunoglobulin G enzyme-linked immunosorbent assays.

Authors:  A L Perry; A J Hayes; H A Cox; F Alcock; A R Parker
Journal:  Clin Vaccine Immunol       Date:  2009-09-30

2.  The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma.

Authors:  Ling Xie; Wen-Kai Ni; Xu-Dong Chen; Ming-Bing Xiao; Bu-You Chen; Song He; Cui-Hua Lu; Xiao-Yan Li; Feng Jiang; Run-Zhou Ni
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-25       Impact factor: 4.553

3.  A lateral flow assay for the determination of human tetanus antibody in whole blood by using gold nanoparticle labeled tetanus antigen.

Authors:  Juanzu Liu; Junyan Wang; Zhaohui Li; Hongmin Meng; Lin Zhang; Hongqi Wang; Jianjun Li; Lingbo Qu
Journal:  Mikrochim Acta       Date:  2018-01-11       Impact factor: 5.833

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.